1. Home
  2. SILO vs ADN Comparison

SILO vs ADN Comparison

Compare SILO & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • ADN
  • Stock Information
  • Founded
  • SILO 2010
  • ADN 2006
  • Country
  • SILO United States
  • ADN United States
  • Employees
  • SILO N/A
  • ADN N/A
  • Industry
  • SILO Apparel
  • ADN Power Generation
  • Sector
  • SILO Consumer Discretionary
  • ADN Utilities
  • Exchange
  • SILO Nasdaq
  • ADN Nasdaq
  • Market Cap
  • SILO 8.8M
  • ADN 7.5M
  • IPO Year
  • SILO N/A
  • ADN N/A
  • Fundamental
  • Price
  • SILO $1.16
  • ADN $2.10
  • Analyst Decision
  • SILO
  • ADN
  • Analyst Count
  • SILO 0
  • ADN 0
  • Target Price
  • SILO N/A
  • ADN N/A
  • AVG Volume (30 Days)
  • SILO 92.8K
  • ADN 21.2K
  • Earning Date
  • SILO 05-12-2025
  • ADN 12-27-2024
  • Dividend Yield
  • SILO N/A
  • ADN N/A
  • EPS Growth
  • SILO N/A
  • ADN N/A
  • EPS
  • SILO N/A
  • ADN N/A
  • Revenue
  • SILO $72,102.00
  • ADN $8,157,000.00
  • Revenue This Year
  • SILO $1.86
  • ADN $2,232.99
  • Revenue Next Year
  • SILO N/A
  • ADN $91.56
  • P/E Ratio
  • SILO N/A
  • ADN N/A
  • Revenue Growth
  • SILO N/A
  • ADN 274.35
  • 52 Week Low
  • SILO $0.77
  • ADN $1.71
  • 52 Week High
  • SILO $4.50
  • ADN $8.79
  • Technical
  • Relative Strength Index (RSI)
  • SILO 47.25
  • ADN 22.88
  • Support Level
  • SILO $0.99
  • ADN $2.49
  • Resistance Level
  • SILO $1.19
  • ADN $2.84
  • Average True Range (ATR)
  • SILO 0.08
  • ADN 0.32
  • MACD
  • SILO 0.02
  • ADN -0.07
  • Stochastic Oscillator
  • SILO 75.00
  • ADN 0.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: